USE OF NAFAZATROM FOR THE THERAPY OF ISCHAEMIAS,DISORDERS IN CARDIAC RHYTHM;INFLAMMATIONS OF EYE AND SKIN;RHEUMATIC,ALLERGIC AND ASTHMATIC DISEASES,ARDS;PULMONARY EMBOLISMS;OEDEMES;PULMONARY HYPERTENSION;OXYGEN INTOXICATION;AND ULCERATIONS

摘要

The present invention relates to the use of 3-methyl-1-[2-(2-naphthyloxy)ethyl]-2-pyrazolin-5-one ("nafazatrom") for the prevention and treatment of myocardial infarcts after myocardial ischaemias and of cardiac dysrhythmias. The invention also relates to antiarrhythmic and antiischaemic pharmaceutical compositions which contain a therapeutically effective amount of nafazatrom.